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ABSTRACT
Objectives: A new generation of neuromuscular
electrical stimulation (NMES) devices can exercise
aerobically at equivalent rates to voluntary exercise.
Many with type 2 diabetes cannot or will not exercise
sufﬁciently. The objective of this pilot investigation was
to see (1) if it was an acceptable training modality for
men with type 2 diabetes mellitus and (2) to assess
effects on haemoglobin A1c levels.
Design, setting, participants and intervention: A
case series of eight men with type 2 diabetes mellitus
(aged 5368; body mass index 3265 5 kg/m
2) trained
with the NMES system for 1 h 6 times weekly for 8
weeks, unsupervised, at home. There were no other
medication or lifestyle interventions. The aerobic
NMES exercise system delivers a repeating set of four
complex staggered pulses at high intensities (typically
100 mA+) through an array of eight thigh electrodes.
Outcome measures: The primary outcome measures
were changes in haemoglobin A1c and the responses
in a questionnaire on participants’ perceptions of the
system. Body mass and composition were also
measured before and after the NMES intervention
period.
Results: All participants could use the system at
a level that left them breathless and sweaty and with
a heart rate over 120 beats per minute. Haemoglobin
A1c levels improved by 0.860.7% from 7.461.3%
(mean 6 SD) to 6.661.0% (p¼0.01). All participants
considered the system suitable for people with
diabetes, would recommend it and would continue to
use it twice a week ‘to maintain improvements’.
Conclusions: These results suggest that aerobic
NMES may be acceptable and have a beneﬁcial effect
on haemoglobin A1c of some men with diabetes. The
treatment may be of particular beneﬁt in those who will
not or cannot do adequate amounts of voluntary
exercise. A randomised control trial is required for
conclusive efﬁcacy data.
INTRODUCTION
A new generation of neuromuscular elec-
trical stimulation (NMES) devices can
exercise aerobically at equivalent rates to
voluntary exercise.
1e5 As many people with
type 2 diabetes cannot or will not exercise
sufﬁciently, a case series was undertaken to
assess the acceptability and efﬁcacy of treat-
ment with this new exercise modality in
a male type 2 diabetic population. There is
consensus among the major diabetes orga-
nisations on the importance of physical
activity in the prevention and treatment of
type 2 diabetes.
67However, there are many
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ARTICLE SUMMARY
Article focus
- Advanced NMES techniques can now deliver
aerobic exercise at training intensities. Improve-
ments in aerobic ﬁtness have been shown in the
healthy, those with cardiac failure and the obese.
- It was hypothesised that this could be of beneﬁt
to those with type 2 diabetes, particularly those
with barriers to voluntary exercise.
- A pilot study was undertaken to assess the
system and its effects on HbA1c.
Key messages
- All participants could use the system, unsuper-
vised, at home, at intensities that made them
sweaty and breathless.
- Average improvement in HbA1c of 0.8
6 0.7% (p¼0.01) is consistent with exercise
interventions.
- The system may be an alternative for patients
that will not or cannot undertake voluntary
exercise.
Strengths and limitations of this study
- The technology used is now well proven to have
substantial aerobic training effects in other
groups.
- There were no other lifestyle interventions.
- This is a small uncontrolled pilot study on
a group of men who pro-actively volunteered
for participation in an exercise programme. While
the results are promising, it was not a rando-
mised controlled trial, and the sample may not be
representative of patients with type 2 diabetes
mellitus.
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Open Access Researchreal and perceived barriers to exercise in this group
8
including obesity.
9 There are those who cannot exercise,
for example, at an extreme people with spinal cord
injuries. There are those who have relative barriers to
exercise, commonly due to musculoskeletal conditions,
particularly arthritis. People with arthritis exercise less
10;
there are 21.1 million US adults with arthritis-attribut-
able activity limitation.
11 There are over 10 million in the
USA with diabetes and arthritis.
12 Additionally, there are
those who could but will not exercise sufﬁciently,
perhaps due to the commitment required, particularly
time commitment, or a host of psychological or other
barriers.
13 De facto, standard exercise regimes are
insufﬁciently appealing to the many who could but do
not regularly exercise.
14
NMES has been used for many decades to elicit muscle
contractions with an electrical impulse. A sophisticated
NMES device (NT2010 Research Stimulator; Bio-Medical
Research Ltd, Galway, Ireland) seems to offer a genuine
alternative to vigorous voluntary aerobic exercise. It can
deliver complex pulses in unusual patterns that seem to
be well tolerated at high intensities (up to 200 mA). A
technical description of the system is given below; at the
time of writing, they are still prototype devices. Previous
studies have demonstrated that using this, NMES
subjects can increase maximum aerobic capacity
(VO2max), typically by around 10% over a 6e8 week
training period. This has been shown in the compara-
tively ﬁt,
2 those with cardiac failure,
3 the sedentary
4 and
in the patients with obesity. At aggressive intensities
(160e200 mA), it has been shown to induce a maximal
heart rate while exercising at over 75% of VO2max.
1 Even
traditional NMES techniques exercising at just two
metabolic equivalents (oxygen consumption of 7 ml/
kg/min) has been shown to enhance total body glucose
uptake and attenuate postprandial hyperglycemia in the
obese.
15 The therapeutic potential of traditional NMES
on diabetes has been investigated previously with no
improvement in haemoglobin A1c (HbA1c) or insulin
sensitivity.
16 However, as a traditional NMES system was
used, this had little physiological impact on study
participants, for example, there was only a 9% increase
in energy expenditure above baseline values. The HbA1c
assay measures chronic glycemia and is widely used to
judge the adequacy of diabetes treatment.
17 A related
technology, described as ‘high frequency NMES’, was
initially shown to have an effect on HbA1c.
18 Further
investigation did not appear to support this claim;
however, it may have a beneﬁcial effect on diabetic
neuropathies.
19 20 This ‘high frequency NMES’ appears
to have negligible aerobic effect and so would probably
have a different mechanism of action.
A small pilot study in patients with obesity 41 6
5.5 kg/m
2 suggested that the aerobic NMES system may
be more suited to obese men than obese women. In
a supervised session, the men (n¼3) could exercise at an
average rate of 549 kcal over 1 h, including 30 min at
8868% of their maximal heart rate and 59.969.6% of
their maximal aerobic capacity VO2max. By contrast, the
women could only exercise at a rate of 203 kcal, 6369%
of their maximal heart rate and 41.1612.0% VO2max. All
three men found the treatment ‘highly acceptable’, and
the female participants had a more mixed reaction.
Hence, it was decided to ﬁrst assess the NMES system on
men with diabetes only.
NMES systems that can deliver aerobic exercise could
contribute towards the physical activity needs of patients
with type 2 diabetes. An ideal system would not load the
joints and could exercise with no gross hip or knee
movements, it could be used even in the arthritic or
those with peripheral neuropathies and could be used
without supervision in the privacy of one’s home while
sitting watching television or reading. A foolproof system
with rapid application that was acceptable and tolerable
at therapeutic intensities may be appealing to both
patients and clinicians. The objective of this pilot inves-
tigation was to see if (1) this new exercise modality was
acceptable to and could be used by a sample of men with
type 2 diabetes mellitus and (2) to assess if training with
it over 8 weeks, unsupervised and at home, had an effect
on haemoglobin A1c.
PATIENTS AND METHODS
Approval for the case series was given by the local
university human research ethics committee.
Recruitment and screening
Participants were recruited by an advert placed in a local
newspaper; this advert explicitly mentioned exercise: .
study ‘investigating the beneﬁts of a new form of exer-
cisedcan do watching TV, etc.’. It sought men with type
2 diabetes of less than 65 years who were diagnosed
within the previous 5 years and were otherwise in good
general health. Twenty-ﬁve potential participants (plus
two people on behalf of relatives) contacted the
researcher by phone for further information. All
respondents were Caucasian. After telephone screening,
see exclusion criteria in box 1, 12 subjects were invited
into the university for further screening, information
and to assess whether, after trying the device, they would
like to participate in the study. Informed consent and
permission from their personal doctor or endocrinolo-
gist was obtained. Where indicated an exercise cardiac
stress test was completed prior to enrolment. One
subject was unsure whether he wished to proceed. He
immediately withdrew citing dislike of the sensations
caused by the NMES. Of the remaining 11 participants,
one withdrew due to repeated machine failures and two
withdrew for personal reasons unrelated to the NMES.
Hence, eight subjects were trained with the NMES. They
had a body mass index of 3265 5 kg/m
2 and were
5368 years old. There was no lifestyle or medication
changes or signiﬁcant weight ﬂuctuation over the
preceding 3 months. Three undertook no regular exer-
cise, four exercised two-to-four times weekly and one
exercised daily. During this introductory session, lasting
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120 beats per minute or more. This was assessed by
palpation. All expressed conﬁdence that they could
apply the electrodes and control the stimulation without
supervision.
Intervention
The eight participants were asked to train with the
NMES, unsupervised, at home, for 45 min to 1 h, six
evenings a week, for eight weeks. All patients received at
least 6-weeks training. (One patient was measured in the
seventh week due to unexpected and unavoidable
foreign travel. One missed several days training in the last
week due to NMES unit failure.) Self-reported compli-
ance was at least ﬁve times per week on average for all
participants. The NMES unit had a built-in crude
compliance monitor that would be supportive of the
participants’ stated usage levels. Whenever possible, they
were instructed to train after their evening meal and not
to eat prior to bed. There were no other dietary restric-
tions, lifestyle changes or medication changes required.
Technical description of the aerobic NMES stimulation
system
The pulses were delivered through an array of eight
large hydrogel electrodes, 17310.3 cm, applied to the
skin using two neoprene wrap garments, one applied to
each thigh, see ﬁgure 1. The electrodes were pre-wired
and mounted for convenient rapid and correct applica-
tion. In ﬁgure 1, the model’s left leg is without the
garment to illustrate electrode positioning. The basic
NMES pulse pattern is a composite of four pulses shared
between the electrode array (ﬁgure 2). Repeating the
pulse pattern at 5 Hz induces a strong non-fused non-
tetanic contraction of the large muscle groups in the legs
(quadriceps, hamstrings, gluteal and calf muscles).
The pulses were created using a programmable
NT2010 research stimulator (Bio-Medical Research Ltd).
This device allows for more complex pulses and pulse
patterns than would be typical. A simpliﬁed schema of
the pulse pattern is shown in ﬁgure 2. Pulses 1, 2 and 3
were 760 ms long; pulse 4 was 857 ms. All pulses are
biphasic, symmetrical with an interphase delay of 100 ms.
In turn, each pulse is divided into separate segments
called timeslots. There were between three and ﬁve
timeslots per pulse. For each of the 16 timeslots (in the
ﬁrst phase of the pulses), a subset of the electrode array
has been designated as source or sink of the current.
Furthermore, each timeslot can be allocated
a percentage of the maximum current availabledset by
the user-controlled intensity button. For instance, for
user comfort, the timeslot targeting vastus medialis is set
at 60% of those targeting the proximal quadriceps.
Using this system, the current densities ‘seen’
throughout the thigh can be optimised. The variability
of this system enables the targeting of the gluteal and
Box 1 Exclusion criteria
- Women
- >65 years
- Diagnosed as having diabetes more than 5 years ago
- Not within easy commute of the university
- Change of lifestyle in last 3 months (deemed by
researcher to be relevant)
- Self-reported ﬂuctuation in weight of over 3 kg/6 lbs in
the past 3 months
- Other metabolic or hormonal disorder
- Blood clotting disorder
- Metal implants or cardiac pacemakers
- Inﬂammatory rheumatological disease
- Fractures during the past 6 months
- Lower extremity trauma during the past 6 months or
currently experiencing related symptoms or receiving
treatment
- Epilepsy
- Neoplastic disease
- Previous stroke
- Alzheimer’s disease
- Serious respiratory disorder
- Parkinson’s disease
- Major musculoskeletal disease/disorders
- Medically diagnosed osteoporosis
- Uncontrolled hypertension
- Previous myocardial infarction
- Cardiac arrhythmias
- Use of b blockers
- Skin condition that may interfere with the delivery of the
NMES
- Addicted to alcohol or drugs that interfere with the
neuromuscular system
- Using insulin/injections of any kind
- Any other condition or history that the investigator
considers might increase the risk to the individual or
interfere with the study or the evaluation of data
Figure 1 Four large hydrogel electrodes are applied to the
skin of each thigh using a neoprene wrap. The electrodes were
pre-wired and mounted inside the wrap. The model’s left leg is
without the garment to illustrated electrode positioning.
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these muscles, for example, the motor neurons
supplying the calf muscle are stimulated as they traverse
the upper leg.
Measurements and statistical analysis
Preweight and postweight, dual energy x-ray absorpti-
ometry (DXA) scans (GE Healthcare, Waukesha,
Wisconsin, USA) and venous blood samples, for HBA1c,
were taken. The samples were refrigerated, then
collected and analysed by an accredited laboratory (I-
NAB; ISO 15189). Afterwards, the participants ﬁlled in
a brief questionnaire given to them by the researcher.
Two participants did not ﬁll in the questionnaire, they
were later phoned and their responses were noted. The
questionnaire asked (1) What I liked most about it; (2)
What I liked least about it; (3) As a form of exercise do
you think it is suitable for diabetics? (4) If it brings about
an improvement in diabetes but people still had to take
medication would you recommend it? (5) If you needed
to continue using it twice a week to maintain improve-
ments in diabetes would you do it? (6) Suggestions and
(7) Other comments.
The objective measures, see table 1, were analysed by
comparing before and after data using a two-tailed
paired Student t test. As this was a pilot study on a novel
therapy, there was no a priori power calculation. The
questionnaire was qualitative by its nature. Questions 3-5
inclusive invited a yes/no response.
RESULTS
The results, displayed in table 1, show mean HbA1c
levels improved by 0.860.7% (mean 6 SD) from
7.461.3% prior to intervention to 6.661.0% post-
intervention (p¼0.01). The four participants with
a starting HbA1c of less than seven improved from
a mean of 6.5%e6.0% and those with a starting value of
seven or more improved from a mean of 8.4%e7.3%.
Removing any one subject from the statistical analysis
still leaves a statistically signiﬁcant change in HbA1c of
p¼0.03 or less. The HbA1c for subject 8 was not avail-
able, however, furctosamine data were. This was
converted to HbA1c using the formula %
HbA1c¼0.0173Fructosamine+1.61.
21 Excluding this
subject, the mean before %HbA1c is 7.561.4%, mean
after %HbA1c is 6.761.0%, the change  0.7 6 0.7% and
p value is 0.03. Changes in mass and lean mass were not
statistically signiﬁcant. Mean mass decreased by
0.762.7 kg (p>0.05), while mean lean mass increased by
80861762g (p>0.05).
From the questionnaire, all eight participants consid-
ered that the system suitable for people with type 2
diabetes mellitus would recommend it and would
continue to use it twice a week ‘to maintain improve-
ments’. Three disliked the electrodes, one complained
of hamstring cramps. What participants ‘liked most
about it’ varied, ‘improved energy levels’, ‘work up
a good sweatdit could be done anywhere in the house,
watching TV, etc.’ ‘feeling afterwardsdlike playing
football when I was younger’.
DISCUSSION
The average improvement in HbA1c of 0.860.7% is
clinically signiﬁcant and compares well to other lifestyle
interventions where an exercise effect of 0.62%
improvement can be expected.
22 The only intervention
study in patients with type 2 diabetes with standard
NMES
16 did ‘not show any metabolic beneﬁt’. Although
it showed that the NMES ‘mimics acute exercise. the
magnitude of this change is too small to have any clinical
Figure 2 Simpliﬁed diagram of pulse pattern. Each pulse is
represented by a different colour. The current passes between
different sets of electrodes within each pulse. The electrodes
are described by their position, that is, RUQdright upper
quadriceps electrode, RUHdright upper hamstring,
RLQdright lower quadriceps, etc. See also Figure 1 for picture
of electrode positions. The pattern has four pulses; within this
pattern, the pulses are separated by either 40 or 5 ms. For
aerobic effect, the pattern is repeated ﬁve times per second.
Each pulse has a different function and is further subdivided
into timeslots. Differing electrode combinations are active
during separate timeslots of a given pulse, for example, pulse
1, in red, is shared between the upper and lower quadriceps of
both legs. By deﬁning the timeslots, the upper quadriceps ‘see’
both a higher current intensity and a longer pulse duration than
the lower electrodes. (This is not shown.) The second pulse, in
blue, has ﬁve timeslots, and it targets the muscle bulk of the
right leg. The third pulse, in green, follows 5 ms later; it is
similar to the second pulse except it targets the muscle bulk of
the left leg. Forty millisecond later, the fourth pulse, in black,
spreads current between the hamstring electrodes.
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that the NMES can induce large metabolic demand.
1e5
The full extent of the improvement may not be captured
by the HbA1c as the intervention period was only 8
weeks in duration. The slight mass decrease
(0.762.7 kg) makes it unlikely that dieting or other
lifestyle modiﬁcations were the driver of the HbA1c
changes. Several participants commented that they liked
not being asked to lose weight or make other lifestyle
modiﬁcations. However, in the formal debrieﬁng after-
wards, two participants reported changes in diet. Subject
1 said he ate fewer home-baked delicacies than usual.
Subject 4 reduced his alcohol intake (from a reported
‘can of beer most evenings’). Removing subjects 1 and 4
from the analysis still leaves a statistical signiﬁcance of
p<0.02 for changes in HbA1c.
The changes in lean mass are not statistically signiﬁ-
cant and vary considerably between subjects (mean 6
SD: 0.861.7 kg). This may be partly due to the small
numbers and the testeretest reliability of the system. GE
Healthcare report that for the system used (Lunar
iDXA), ‘statistically 68% of repeat scans fall within 1 SD
. 6 310 g lean mass’. Presumably, this reliability would
further deteriorate when separated by 2 months and
subjects having different hydration levels and mass, etc.
Surprisingly, the only subject to increase his HbA1c put
on the most lean mass according to the DXA scan.
All participants found the treatment acceptable and,
tellingly, all would like to be contacted for further
research on it. All reported that they would like to
continue using the device ‘twice a week to maintain
improvements’. While not explicitly sought on the
questionnaire, the participants would not wish to
continue exercising with it six times weekly. The results
of the questionnaire were uniformly positive. However,
this probably partly reﬂects selection bias and their
participation in the study. They were a pro-active group
who volunteered for an exercise study.
The sensation of exercising without volitional
contractions is, at ﬁrst, strange to many. Accommodation
and habituation to the stimulation proved to be impor-
tant both within and between sessions. This habituation
process is typical of NMES.
23 All participants had shown
that they could use the system at a level that induced
a heart rate of at least 120 bpm in the observed intro-
ductory session. All reported that they could use it at
levels that made them sweaty and breathless (affects
speech). This probably compares well to actual practice
in the target population. In a study of over 400 patients
with type 2 diabetes mellitus, Thomas reports that ‘only
9% of these patients exercised sufﬁciently to achieve
a large change in heart rate or breathing’.
24
Intriguingly, there may be particular advantages of this
exercise modalitydespecially when used in addition to
voluntary exercise. NMES is thought to preferentially
recruit different motor units in position and in type.
25
Kimura et al
15 has argued the potential beneﬁts in type 2
diabetes of a higher proportion of type IIb ﬁbres being
exercised. If a person both walks and uses this modality,
then there will be a different ﬁbre mix recruited by each
exercise type and the total proportion of ﬁbres exercised
will be higher. Furthermore, traditional NMES tech-
niques are known to elicit different metabolic adapta-
tions compared with voluntary exercise. Gondin et al
26
showed a signiﬁcant shift in muscle ﬁbre type from
myosin heavy chain (MHC) MHC-2X towards MHC-2A
and MHC-1 and evidence of a muscle ﬁbre shift towards
oxidative metabolism, that is, a glycolytic-to-oxidative
shift in the metabolic proﬁle. It is unclear if the new
NMES techniques will induce a similar metabolic effect.
However, strength increases in addition to increases in
aerobic capacity have been noted.
3 Exercising with this
system appears to preferentially use carbohydrate as
a substrate, that is, exercise at a very high respiratory
quotient. This has been documented in a healthy
subject
12 7but has also been noted in a group of nine
patients with morbid obesity (unpublished data).
Consistent with this is high lactate levels, up to
15.3 mmol/L, that have been recorded.
1 This has also
been noted with traditional NMES techniques.
28 The
Table 1 Preintervention and postintervention values for %HbA1c, mass and lean mass
%HbA1c
preintervention
%HbA1c
postintervention
%HbA1c
change
Mass (kg)
preintervention
Mass (kg)
postintervention
Mass (kg)
change
Lean (g)
change
1 6.1 6.1 0 115 110.6  4.4  442
2 6.6 6.7 0.1 147.8 149 1.2 3277
3 9.4 7.4  2 102.2 102.1  0.1 1073
4 6.2 5.5  0.7 91 85.6  5.4  1939
5 9.5 8.5  1 93 94.8 1.8 1249
6 7.8 7  0.8 87.3 87.5 0.2 28
7 7 6.2  0.8 78.4 78  0.4 N/A
8 6.9* 5.7*  1.2 115.7 116.9 1.2 2411
Mean6SD 7.461.3 6.661.0  0.860.7y 103.8 622.0 103.0622.6  0.762.7z 80861762x
*HbA1c result not available. Figures derived from glycosylated fructosamine (mmol) using the formula: %HbA1c ¼0.017 3 Fructosamine +
1.61
21
yp¼0.01.
zp>0.05.
xp>0.05.
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proﬁle more consistent with vigorous voluntary
exercisedan exercise intensity that many with type 2
diabetes may not engage in sufﬁciently.
24 The role of
lactate may be signiﬁcant; Sola-Penna
29 argues that
lactate may no longer be considered a ‘worthless
metabolite’ but ‘a regulatory molecule that modulates
the integration of metabolism’ including glucose.
The positive reaction from the participants and the
improvements in HbA1c gives us conﬁdence that the
system may have a role to play in treating some of those
with type 2 diabetes. It may be particularly suited to those
with barriers to voluntary exercise, for example, the high
proportion of patients with arthritis-attributable activity
limitation.
11 12 There are no gross movements in the
hips or the knees, excepting some patellar gliding, and it
does not load the joints. Some may like to use it simply
out of preference over voluntary exercise or for its
convenience or because it is a ‘passive’ exercise and can
be done in private while watching television. In the unﬁt,
there appears to be no minimum threshold of exercise
intensity to reap beneﬁts.
30 This may also apply to this
system of exercise. Women with obesity seem less likely to
exercise with this at levels greater than 40% of VO2
reserve (unpublished data). Perhaps, the system could
be used at lesser intensity for longer. US adults still watch
an average of 153 h of television per month.
31 Total
sitting time is associated with weight gain independently
of leisure time physical activity
32 and television watching
is also independently associated with increased risk of
type 2 diabetes.
33 Some of this sitting time could become
physical activity. A ﬁt person using this NMES system
while watching television for 6 h burnt over 2200 kcal.
1 A
greater understanding of the mechanisms of action may
help further improve the efﬁcacy of the treatment. For
instance, the present system is optimised to maximise
oxygen consumption; however, preliminary testing
suggests that it can be further modiﬁed to give a higher
lactate output for a given oxygen consumption.
Further investigation of the system on a larger group,
with a control arm and double blinding, seems warranted.
Of particular interest would be a study of those who have
signiﬁcant barriers to voluntary exercise but can exercise
with this system. A greater understanding of the metab-
olism of this exercise modality may suggest further
improvements to the system. The authors have also
hypothesised that the system may have a potential appli-
cation as part of a novel accelerated programme to help
prevent the progression of diabetes/prediabetes.
27
This was a small pilot study undertaken in a group of
pro-active enthusiastic men with type 2 diabetes. While
the results are promising, it was not a randomised
controlled trial, and the sample was not representative of
the 366 million
34 people with diabetes.
CONCLUSION
The results of this pilot investigation are encouraging
and suggest, for the ﬁrst time, a viable aerobic exercise
alternative that may be suitable for some with type 2
diabetes who cannot or will not engage in voluntary
exercise.
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